Showing results (51-60 of 5,335) with videos related to
Sort By:
Pageof 534
Clinical and Experimental Immunology|September 1, 1988
Measurement of terminal complement complexes in rheumatoid arthritisB P Morgan, R H Daniels, B D WilliamsImmunology|August 14, 1999
Tissue distribution of the rat analogue of decay-accelerating factorO B Spiller, S M Hanna, B P MorganThe Biochemical Journal|July 27, 1999
Molecular and functional analysis of mouse decay accelerating factor (CD55)C L Harris, N K Rushmere, B P MorganImmunology|August 6, 2000
Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activitiesC L Harris, O B Spiller, B P MorganJournal of Neuroimmunology|May 26, 1998
The expression of complement regulatory proteins by adult human oligodendrocytesN J Scolding, B P Morgan, D A CompstonBritish Journal of Rheumatology|August 1, 1986
The ninth complement component in rheumatoid arthritis, Behçet's disease and other rheumatic diseasesW R Rumfeld, B P Morgan, A K CampbellBiochemical and Biophysical Research Communications|January 30, 1984
Inhibition of complement-induced [14C]sucrose release by intracellular and extracellular monoclonal antibodies to C9: evidence that C9 is a transmembrane proteinB P Morgan, J P Luzio, A K CampbellJournal of Neuroimmunology|May 1, 1996
Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteinsP Gasque, A Thomas, M Fontaine, et al.Clinical and Experimental Immunology|January 13, 2000
Comparison of the suppressive effects of soluble CR1 and C5a receptor antagonist in acute arthritis induced in rats by blocking of CD59M Mizuno, K Nishikawa, B P Morgan, et al.Immunology|November 1, 1994
Altered glycosylation and selected mutation in recombinant human complement component C9: effects on haemolytic activityK M Taylor, B P Morgan, A K CampbellPageof 534